Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

3.50
-0.1300-3.58%
Volume:726.43K
Turnover:2.57M
Market Cap:238.48M
PE:-3.43
High:3.76
Open:3.70
Low:3.48
Close:3.63
Loading ...
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Major Issues Report

Form 8-K - Current report